TEQCool’s intended therapy is dedicated to achieving and maintaining normothermia in the patient’s brain. The primary objective of the treatment is to prevent and manage neurogenic fever in brain–injured patients. The system will support healthcare professionals to achieve stable normothermia by continuous regulation of brain temperature.
The cooling is transferred to the patient via balloon catheters placed in the nasal cavity. The physiological proximity of the nasal cavity to the brain results in short response time and more precise brain temperature control.
Healthcare professionals can thereby freely access the patient body throughout the cooling treatment which minimizes impact on the patient care. The treatment does not require any surgical procedures and is minimally invasive.